517. RELATIONSHIPS OF LUTEAL PHASE VARIABLES (PRIOR TO AI) WITH FOLLICULAR WAVES IN DAIRY COWS

2009 ◽  
Vol 21 (9) ◽  
pp. 116
Author(s):  
E. Dirandeh ◽  
H. Kohram ◽  
M. Aryanezhad

This study was done to consider relationships of luteal phase variables (prior to AI) with follicular waves. The estrous cycles of 10 cows were synchronized with 2 im injections of prostaglandin F2α given 11 d apart. The cows were randomly assigned to 1 of 2 treatments. Cows in the control treatment received no treatment, whereas GnRH6 cows received a GnRH injection on d 6 of the estrous cycle (estrus = d 0). Daily, from estrus d 0 to the next estrus d 23, cows had their ovaries scanned by ultrasound. Blood samples were collected by tail following each ultrasound examination from estrus until next estrus (estrus = d 0). Concentrations of plasma progesterone were determined by radioimmunoassay kit. The limit of detection of the assay was 0.125 ng/mL and the intra- and interassay coefficients of variation were 8.4% and 10.2%, respectively. Data that were analyzed by using PROC GLM of SAS. For comparisons between groups, the 2-sample t-test was used for continuous traits, such as size of cl or hormone concentrations. Prospective comparisons of indices of progesterone indicated that the length of luteal lifespan was longer in three-wave than in two-wave cows (P<0.01). Plasma progesterone concentrations were similar at peak and measured as area under the curve on day 5 through 17 preceding insemination in two-wave (6.70±0.30 ng/ml) and three-wave cows (7.30±0.50 ng/ml). Length of the luteal phase (defined as from the day of estrus until the last day on which plasma progesterone remained greater than 2 ng/ml) was <2 days shorter in two-wave cows than in three-wave cows (16.7±0.30 vs. 18.40±0.50 d; P<0.05). In addition, the day of peak progesterone occurred earlier in two-wave cows (13.50±0.40 vs. 16.30±0.70 d; P<0.05).

2010 ◽  
Vol 22 (1) ◽  
pp. 379
Author(s):  
H. Kohram ◽  
G. Mohammadi ◽  
E. Dirandeh

This study was done to consider relationships of luteal phase variables (prior to AI) with follicular waves. The estrous cycles of 15 buffaloes were synchronized with 2 i.m. injections of prostaglandin F2α given 11 days apart. The buffaloes were randomly assigned to 1 of 3 treatments. Buffaloes in the control treatment received no treatment, whereas G6 buffalos received a GnRH injection between Day 5 and 7 and G16 buffalos received a GnRH injection between Day 15 and 17 of the estrous cycle (estrus = Day 0). Daily, from estrus Day 0 to the next estrus Day 23, buffaloes had their ovaries scanned by ultrasound. Blood samples were collected by tail following each ultrasound examination from estrus until next estrus (estrus = 0). Concentrations of plasma progesterone were determined by radioimmunoassay kit. The limit of detection of the assay was 0.1 45 ng mL-1 and the intra- and interassay coeffients of variation were 7.4% and 9.2%, respectively. Data were analyzed by using PROC GLM of SAS (SAS Institute, Cary, NC, USA). For comparisons between groups, the 2-sample t-test was used for continuous traits, such as size of CL or hormone concentrations. Prospective comparisons of indices of progesterone indicated that the length of luteal lifespan was longer in 3-wave than in 2-wave buffaloes (P < 0.01). Plasma progesterone concentrations were similar at peak and measured as area under the curve on Day 5 through 17 preceding insemination in 2-wave (5.30 ± 0.40 ng mL-1) and 3-wave buffaloes (5.10 ± 0.20 ng mL-1). Length of the luteal phase (defined as from the day of estrus until the last day on which plasma progesterone remained >2 ng mL-1) was <2 days shorter in 2-wave buffaloes than in 3-wave buffaloes (15.20 ± 0.40 v. 17.10 ± 0.50 d; P < 0.05). In addition, the day of peak progesterone occurred earlier in 2-wave buffaloes (13.50 ± 0.30 v. 15.30 ± 0.70 d; P < 0.05).


2009 ◽  
Vol 21 (1) ◽  
pp. 184
Author(s):  
E. Dirandeh ◽  
H. Kohram ◽  
A. Zare Shahneh

It is suggested that pregnancy rate is greater in lactating cows inseminated following ovulation of a third-wave follicle compared with a second-wave follicle. The number of follicular waves is not apparent during the estrous cycle. However, GnRH injection on Day 6 is supposed to initiate a new follicular wave earlier; as a result, the number of cows with 3 follicular waves will be increased. This study was done to change the 2-follicular-wave cycles to 3 follicular waves during the estrous cycle. The estrous cycles of 10 cows were synchronized with 2 i.m. injections of prostaglandin F2α given 11 days apart. The cows were randomly assigned to 1 of 2 treatments. Cows in the control treatment received no treatment, whereas GnRH6 cows received a GnRH injection on Day 6 of the estrous cycle (estrus = Day 0). Ovaries of all cows were scanned daily, from estrus (Day 0) to the subsequent estrus (Day 23). Profiles of the mean number of follicles (i.e. 4- to 6-mm and ≥7 mm), the diameter of the largest follicle (F1), and comparison of 2- and 3-wave cows were compared by least squares analysis of variance using the general linear model (GLM) procedure of SAS. The number of 4 to 6 mm follicles had a tendency to decline until Day 6 (3.0 ± 2.1 v. 0.8 ± 1.6). In response to an injection of GnRH, the number of small follicles in group GnRH6 on Day 6 (1.5 ± 1.6 follicles) increased (P < 0.05) on Day 8 (5.0 ± 1.7 follicles) and the number of medium and large follicles (≥7 mm) on Day 6 (1.8 ± 0.5 follicles) decreased (P < 0.05) on Day 9 (0.8 ± 0.6 follicles). Over the 4-day period before GnRH treatment, the diameter of F1 was increasing (from 4.7 ± 0.9 mm to 10.0 ± 0.6 mm) in cows treated with GnRH on Day 6 of the estrous cycle; thereafter, the diameter of the F1 decreased (P < 0.05) within 2 days of GnRH treatment. In the control group the diameter of the F1 increased over the 4-day period before GnRH treatment (from 5.0 ± 0.9 mm to 11.2 ± 0.6 mm), whereas it remained constant (11.2 ± 1.2 mm to 11.2 ± 1.2 mm) between Days 6 and 9 of the estrous cycle (P < 0.003). Results showed that 4 out of 5 cows in control group had 2 follicular waves, whereas all of the cows (n = 5) in GnRH6 group had 3 follicular waves. The first follicular wave begins at Day 1.1 ± 0.50 and 0.70 ± 0.50 in the control and GnRH groups, respectively. The second follicular waves appeared at Day 11.00 ± 0.80 and 8.30 ± 1.50 (P ≤ 0.05) for the 2- and 3-wave animals, respectively. The third follicular waves (n = 6) initiated at Day 16.30 ± 1.50. Cows with 2 follicular waves had shorter estrous cycles (P ≤ 0.05) than 3-wave cows (20.50 ± 0.60 v. 22.40 ± 0.90). The ovulatory follicle in 2-wave cows grew larger (14.00 ± 1.80 v. 12.50 ± 0.90 mm; P ≤ 0.05), and maintained for a longer period of time (9.50 ± 1.80 v. 6.1 ± 0.90; P ≤ 0.05) than in 3-wave cows. In conclusion, an injection of GnRH on Day 6 of the estrous cycle could promote the emergence of a new follicular wave earlier in cows and alter the estrous cycles with 2 waves into 3 follicular waves.


1979 ◽  
Vol 91 (3) ◽  
pp. 529-537 ◽  
Author(s):  
Ch. V. Rao ◽  
V. L. Estergreen ◽  
F. R. Carman ◽  
G. E. Moss

ABSTRACT A total of 15 corpora lutea representing early (day 3), mid (day 13) and late luteal phase (days 20 and 21–24) were obtained by ovariectomy on cycling cows. The luteal weights and peripheral plasma progesterone levels just prior to ovariectomy, were consistent with the above luteal phases. The specific binding of [125I]human chorionic gonadotrophin to membranes prepared from corpora lutea was significantly higher (P < 0.01) for days 13 and 20 than for days 3 and 21–24. The binding in day 21–24 corpora lutea was higher (P < 0.01) than day 3. Although there was no difference either in number or affinity (apparent dissociation constant (Kd) = 0.04 nm) of gonadotrophin receptors in days 13 and 20 corpora lutea, only in the former did the binding correlate well with plasma progesterone levels. The specific binding of [3H]prostaglandin (PG)F2α to the membranes of these same corpora lutea showed a progressive increase (P < 0.01) from day 3, reached the highest value at a time when corpora lutea were actively regressing (day 20) and then declined (P < 0.01) by day 21–24. Although a considerable number of PGF2α receptors existed at day 13, the affinity of these same receptors was 203 times lower (Kd = 3458 nm) than the affinity of receptors in day 20 corpora lutea (Kd = 17 nm). In summary, the above results show that gonadotrophin receptors correlate with luteotrophic, whereas PGF2α receptors correlate with luteolytic phases in bovine corpora lutea.


1993 ◽  
Vol 120 (1) ◽  
pp. 103-106 ◽  
Author(s):  
E. R. Mutiga ◽  
E. Mukasa-Mugerwa ◽  
T. Azage

SUMMARYThe luteolytic effect of prostaglandin F2α (PGF2α) during the confirmed luteal phase of the oestrous cycle was evaluated in ten Boran and ten Boran × Friesian cross-bred heifers. Following injection with 25 mg Lutalyse, animals were bled every 6 h for 96 h and plasma progesterone (P4) determined by the ELISA technique. Borans had significantly (P < 0·05) smaller corpora lutea (12·01±0·72 ν. 17·03±2·10 mm) and responded faster to PGF2α injection (65·57±1·40 ν. 78·27±2·18 h) than the cross-bred heifers. However, there was no significant difference in either the initial P4 values (6.24±0·98 ν. 8·00±1·71 ng/ml) or the rate of its decline following PGF2α injection between the two breeds. Values declined sharply to basal levels (11% of the initial pretreatment values) within 48 h in both breeds. All ten cross-breds and eight Borans showed standing oestrus within a week of treatment. However, oestrus was better synchronized (P < 0·05) in Borans than cross-breds. It was concluded that PGF2α is effective for oestrus synchronization in both breeds, but oestrus occurred earlier and was more precise in Borans than in cross-breds.


Author(s):  
Peter A. Kavsak ◽  
Tara Edge ◽  
Chantele Roy ◽  
Paul Malinowski ◽  
Karen Bamford ◽  
...  

AbstractObjectivesTo analytically evaluate Ortho Clinical Diagnostics VITROS high-sensitivity cardiac troponin I (hs-cTnI) assay in specific matrices with comparison to other hs-cTn assays.MethodsThe limit of detection (LoD), imprecision, interference and stability testing for both serum and lithium heparin (Li-Hep) plasma for the VITROS hs-cTnI assay was determined. We performed Passing-Bablok regression analyses between sample types for the VITROS hs-cTnI assay and compared them to the Abbott ARCHITECT, Beckman Access and the Siemens ADVIA Centaur hs-cTnI assays. We also performed Receiver-operating characteristic curve analyses with the area under the curve (AUC) determined in an emergency department (ED)-study population (n=131) for myocardial infarction (MI).ResultsThe VITROS hs-cTnI LoD was 0.73 ng/L (serum) and 1.4 ng/L (Li-Hep). Stability up to five freeze-thaws was observed for the Ortho hs-cTnI assay, with the analyte stability at room temperature in serum superior to Li-Hep with gross hemolysis also affecting Li-Hep plasma hs-cTnI results. Comparison of Li-Hep to serum concentrations (n=202), yielded proportionally lower concentrations in plasma with the VITROS hs-cTnI assay (slope=0.85; 95% confidence interval [CI]:0.83–0.88). In serum, the VITROS hs-cTnI concentrations were proportionally lower compared to other hs-cTnI assays, with similar slopes observed between assays in samples frozen <−70 °C for 17 years (ED-study) or in 2020. In the ED-study, the VITROS hs-cTnI assay had an AUC of 0.974 (95%CI:0.929–0.994) for MI, similar to the AUCs of other hs-cTn assays.ConclusionsLack of standardization of hs-cTnI assays across manufacturers is evident. The VITROS hs-cTnI assay yields lower concentrations compared to other hs-cTnI assays. Important differences exist between Li-Hep plasma and serum, with evidence of stability and excellent clinical performance comparable to other hs-cTn assays.


Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Anna Slagman ◽  
Julia Searle ◽  
Fabian Holert ◽  
Jörn Ole Vollert ◽  
Reinhold Muller ◽  
...  

Introduction: Mid-regional pro-ANP is mainly synthesized in the atria of the heart and it′s secretion is stimulated by ischemia and distension of the myocardium. Objective: To assess the utility of ANP for rule out NSTEMI in combination with cardiac troponin in unselected patients who attend the Emergency Department (ED) with acute cardiac chief complaints. Methods: Patients with chest pain and dyspnea were enrolled over a period of 30 months in the Emergency Department (n=537). Patients with STEMI were excluded from the analysis as diagnosis is ECG- and not biomarker-based (n=18). Blood samples were drawn within 2 hours after admission. Gold-Standard diagnoses were adjudicated by an independent cardiologist. ANP was measured using the BRAHMS Kryptor MR-proANP assay. The lower limit of detection is 2.1 pmol/l. The 97.5 th percentile of a normal population is 86.2 pmol/l and was applied as a cut-off value in this analysis. Troponin I was measured using the Stratus CS and a cut-off value of 0.1 μg/L was applied. Variables are shown as median (IQR) and 95%-CIs. Results: The median ANP-value in all patients (n=519) was 135 pmol/l. Patients with NSTEMI (n=58) had significantly higher ANP-values (244/104-350 pmol/l) as compared to patients with other diagnoses (126/74-256; p<0.0001). In ROC-analysis ANP had an area under the curve of 0.648 (CI:0.582-0.715) for the diagnosis of NSTEMI. Of all patients, 74.2% were troponin negative at admission (n=385). Of these patients, 32.2% (n=124) were also ANP negative. The prevalence of AMI in this subgroup was 1.6% (n=2). The NPV for the combination of troponin and ANP was 98.4% (CI: 94.3-99.8%) and thus higher than for both markers alone (figure 1). In combination with Copeptin, the NPV increased to 100% (CI: 96.3-100%). Conclusions: ANP has potential for early rule-out of AMI in combination with troponin and, due to a different pathophysiological stimulus, it might be used as part of a triple-marker strategy with copeptin and troponin.


Sign in / Sign up

Export Citation Format

Share Document